Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ADUS NYSE:AUNA NASDAQ:PGNY NASDAQ:WGS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADUSAddus HomeCare$108.44-0.9%$112.53$88.96▼$136.72$2.01B0.81165,415 shs169,918 shsAUNAAuna$6.39+0.1%$6.50$6.11▼$9.38$472.20M2.2548,586 shs59,572 shsPGNYProgyny$23.02-0.9%$21.80$13.39▼$30.42$1.99B1.311.71 million shs793,796 shsWGSGeneDx$80.47-1.5%$74.64$25.32▼$117.75$2.30B2.01824,476 shs496,015 shs10 Stocks Set to Soar in Summer 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADUSAddus HomeCare-0.90%-5.22%-5.24%+7.10%-11.72%AUNAAuna+0.08%+0.39%+0.36%-6.87%-24.79%PGNYProgyny-0.95%-3.20%+9.31%+7.37%-23.27%WGSGeneDx-1.49%-12.42%+20.30%-15.71%+151.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationADUSAddus HomeCare4.9641 of 5 stars3.64.00.05.03.42.53.1AUNAAuna3.4561 of 5 stars3.22.00.00.01.80.03.1PGNYProgyny1.0804 of 5 stars1.31.00.00.02.82.51.3WGSGeneDx3.7877 of 5 stars3.42.00.00.02.35.01.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceADUSAddus HomeCare 3.25Buy$142.5731.47% UpsideAUNAAuna 2.33Hold$10.7067.58% UpsidePGNYProgyny 2.67Moderate Buy$24.094.65% UpsideWGSGeneDx 2.78Moderate Buy$92.3314.74% UpsideCurrent Analyst Ratings BreakdownLatest AUNA, PGNY, ADUS, and WGS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/16/2025ADUSAddus HomeCareJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$150.007/9/2025WGSGeneDxPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOverweight$110.007/8/2025PGNYProgynyLeerink PartnrsSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Strong-Buy7/8/2025PGNYProgynyLeerink PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeMarket Perform ➝ Outperform$28.006/30/2025WGSGeneDxGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$88.00 ➝ $115.006/20/2025ADUSAddus HomeCareJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$150.006/10/2025ADUSAddus HomeCareMacquarieSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$133.005/22/2025AUNAAunaHsbc Global ResSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold5/22/2025AUNAAunaHSBCSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetBuy ➝ Hold$7.905/15/2025WGSGeneDxGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$88.005/12/2025PGNYProgynyCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$23.00 ➝ $21.00(Data available from 7/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookADUSAddus HomeCare$1.15B1.73$5.34 per share20.30$53.52 per share2.03AUNAAuna$1.17B0.40$1.17 per share5.46$5.85 per share1.09PGNYProgyny$1.17B1.69$0.34 per share67.34$4.96 per share4.64WGSGeneDx$330.14M6.95$1.01 per share79.83$8.75 per share9.20Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateADUSAddus HomeCare$73.60M$4.4324.4820.231.556.52%9.23%6.96%8/4/2025 (Estimated)AUNAAuna$29.39M$0.5811.018.08N/A3.67%10.39%2.38%8/19/2025 (Confirmed)PGNYProgyny$54.34M$0.5740.3935.422.394.33%10.90%7.20%8/5/2025 (Estimated)WGSGeneDx-$52.29M-$1.41N/A38.50N/A-11.69%10.17%5.51%7/29/2025 (Estimated)Latest AUNA, PGNY, ADUS, and WGS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/5/2025Q2 2025PGNYProgyny$0.42N/AN/AN/A$315.70 millionN/A8/4/2025Q2 2025ADUSAddus HomeCare$1.45N/AN/AN/A$345.71 millionN/A7/29/2025Q2 2025WGSGeneDx$0.09N/AN/AN/A$86.00 millionN/A5/20/2025Q1 2025AUNAAuna$0.16$0.19+$0.03$0.13$1.12 billion$281.43 million5/8/2025Q1 2025PGNYProgyny$0.45$0.17-$0.28$0.17$307.86 million$324.04 million5/5/2025Q1 2025ADUSAddus HomeCare$1.33$1.42+$0.09$1.16$341.66 million$337.71 million4/30/2025Q1 2025WGSGeneDx$0.11$0.28+$0.17-$0.23$79.90 million$87.12 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthADUSAddus HomeCareN/AN/AN/AN/AN/AAUNAAunaN/AN/AN/AN/AN/APGNYProgynyN/AN/AN/AN/AN/AWGSGeneDxN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioADUSAddus HomeCare0.201.741.74AUNAAuna1.760.830.78PGNYProgynyN/A2.392.39WGSGeneDx0.203.253.07Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipADUSAddus HomeCare95.35%AUNAAunaN/APGNYProgyny94.93%WGSGeneDx61.72%Insider OwnershipCompanyInsider OwnershipADUSAddus HomeCare4.60%AUNAAunaN/APGNYProgyny9.40%WGSGeneDx29.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableADUSAddus HomeCare49,70318.40 million17.55 millionOptionableAUNAAuna14,84274.01 millionN/AN/APGNYProgyny31085.72 million77.66 millionOptionableWGSGeneDx1,20028.53 million20.09 millionOptionableAUNA, PGNY, ADUS, and WGS HeadlinesRecent News About These CompaniesPrincipal Financial Group Inc. Has $6.34 Million Stake in GeneDx Holdings Corp. (NASDAQ:WGS)July 17 at 3:20 AM | marketbeat.comWGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are ...July 16 at 4:47 AM | reflector.comRRosen Law Firm Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGSJuly 15 at 3:03 PM | prnewswire.comGeneDx: Strong Testing Volume And An Invaluable Genomic DatabaseJuly 15 at 3:04 AM | seekingalpha.comWGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your RightsJuly 14 at 2:45 PM | globenewswire.comGeneDx Holdings Corp. (NASDAQ:WGS) CFO Sells $490,854.00 in StockJuly 14 at 4:13 AM | americanbankingnews.comGeneDx (NASDAQ:WGS) Stock Rating Lowered by Wall Street ZenJuly 13, 2025 | americanbankingnews.comGeneDx (NASDAQ:WGS) Rating Lowered to "Hold" at Wall Street ZenJuly 13, 2025 | marketbeat.comKatherine Stueland Sells 3,220 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) StockJuly 12, 2025 | insidertrades.comGeneDx Holdings Corp. (NASDAQ:WGS) CEO Sells $299,460.00 in StockJuly 11, 2025 | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) CFO Kevin Feeley Sells 5,278 SharesJuly 11, 2025 | marketbeat.comWGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your RightsJuly 11, 2025 | globenewswire.comGeneDx (NASDAQ:WGS) Coverage Initiated by Analysts at Piper SandlerJuly 11, 2025 | americanbankingnews.comRosen Law Firm Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGSJuly 10, 2025 | prnewswire.comGeneDx (NASDAQ:WGS) Shares Down 5.1% - Here's WhyJuly 10, 2025 | marketbeat.comPiper Sandler Initiates Coverage of GeneDx Holdings (WGS) with Overweight RecommendationJuly 10, 2025 | msn.comWGS Investor News: If You Have Suffered Losses in GeneDx ... - MorningstarJuly 9, 2025 | morningstar.comMGeneDx a new overweight at Piper Sandler on rare diseases testing marketJuly 9, 2025 | msn.comGeneDx (NASDAQ:WGS) Shares Gap Up - Here's What HappenedJuly 9, 2025 | marketbeat.comGeneDx (NASDAQ:WGS) Coverage Initiated at Piper SandlerJuly 9, 2025 | marketbeat.comPenserra Capital Management LLC Has $1.79 Million Stock Holdings in GeneDx Holdings Corp. (NASDAQ:WGS)July 9, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeAUNA, PGNY, ADUS, and WGS Company DescriptionsAddus HomeCare NASDAQ:ADUS$108.44 -0.99 (-0.90%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$108.45 +0.01 (+0.01%) As of 08:38 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.Auna NYSE:AUNA$6.38 +0.01 (+0.08%) Closing price 07/16/2025 03:57 PM EasternExtended Trading$6.40 +0.02 (+0.23%) As of 07/16/2025 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans in Peru; and dental and vision plans in Mexico. The company was founded in 1989 and is based in Luxembourg, Luxembourg.Progyny NASDAQ:PGNY$23.02 -0.22 (-0.95%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$22.93 -0.09 (-0.39%) As of 09:14 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.GeneDx NASDAQ:WGS$80.47 -1.22 (-1.49%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$78.94 -1.53 (-1.91%) As of 09:21 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AMD Just Triggered a Signal Traders Can’t Ignore JNJ’s Stock Price Is Back in Rally Mode—The Time to Buy Is Now Citigroup Earnings Could Signal What’s Next for Markets This ASML Dip Could Be Gone Before You Know It—Don’t Miss Out Rocket Lab Gets New Street-High Price Target from Citi Super Micro Stock May Benefit as Cooling Demand Takes Off Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters 3 Analysts Set $600 Target Ahead of Microsoft Earnings Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
